Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 11Unknown 6Recruiting 6Terminated 3Not yet recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 6

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Breast 4Other hematologic neoplasm 2

Conditions

Triple Negative Breast Neoplasms 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2HER2-negative Breast Cancer 1Cardiotoxicity 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Anthracyclines × Clear all
NCT07548710 2026-04-23

Study of SA+X in the Treatment of Newly Diagnosed AML

Ruijin Hospital

Phase 2 Recruiting
205 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06802757 2026-02-25

PRISM-TNBC

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
72 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06443645 2026-02-04

SCARA-B

Centre Paul Strauss

Recruiting
50 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT06451861 2025-11-17

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Guangdong Provincial People's Hospital

Phase 2 Recruiting
240 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06102824 2024-11-25

ORIENTA

Guangdong Provincial People's Hospital

Phase 2 Recruiting
252 enrolled
Breast

HER2-negative Breast Cancer

NCT05916755 2023-06-23

PORTRAIT

Vall d'Hebron Institute of Oncology

Recruiting
100 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡